产品简要
公司名称 :
赛默飞世尔
其他品牌 :
NeoMarkers, Lab Vision, Endogen, Pierce, BioSource International, Zymed Laboratories, Caltag, Molecular Probes, Research Genetics, Life Technologies, Applied Biosystems, GIBCO BRL, ABgene, Dynal, Affinity BioReagents, Nunc, Invitrogen, NatuTec, Oxoid, Richard-Allan Scientific, Arcturus, Perseptive Biosystems, Proxeon, eBioscience
产品类型 :
抗体
产品名称 :
p53单克隆抗体(多克隆抗体240)
目录 :
MA5-15244
规格 :
500微升
价格 :
美国447.00
克隆性 :
单克隆
宿主 :
小鼠
共轭标签 :
未共轭
克隆名称 :
多克隆抗体240
反应物种 :
人类, 小鼠, 猕猴
应用 :
免疫印迹, 免疫组化, 免疫细胞化学, 免疫沉淀, 流式细胞仪, 免疫组化-石蜡切片
更多信息或购买 :
文章摘录数: 58
参考文献 |
---|
Stanga S, Lanni C, Sinforiani E, Mazzini G, Racchi M. Searching for predictive blood biomarkers: misfolded p53 in mild cognitive impairment. Curr Alzheimer Res. 2012;9:1191-7 pubmed
|
Graziano S, Gu L, Wang X, Tatum A, Vollmer R, Strauss G, et al. Prognostic significance of mucin and p53 expression in stage IB non-small cell lung cancer: a laboratory companion study to CALGB 9633. J Thorac Oncol. 2010;5:810-7 pubmed
|
Wu Z, Zhang R, Chao C, Zhang J, Zhang Y. Histone deacetylase inhibitor trichostatin A induced caspase-independent apoptosis in human gastric cancer cell. Chin Med J (Engl). 2007;120:2112-8 pubmed
|
Terzi C, Canda A, Sagol O, Atila K, Sonmez D, Fuzun M, et al. Survivin, p53, and Ki-67 as predictors of histopathologic response in locally advanced rectal cancer treated with preoperative chemoradiotherapy. Int J Colorectal Dis. 2008;23:37-45 pubmed
|
Tosun M, Tosun E, Kalkan S, Avunduk M. P53 expression between 13-27 weeks old human male fetus gonads. J Mol Histol. 2007;38:271-4 pubmed
|
Nijhof J, Mulder A, Speksnijder E, Hoogervorst E, Mullenders L, de Gruijl F. Growth stimulation of UV-induced DNA damage retaining epidermal basal cells gives rise to clusters of p53 overexpressing cells. DNA Repair (Amst). 2007;6:1642-50 pubmed
|
Ramalingam S, Honkanen P, Young L, Shimura T, Austin J, Steeg P, et al. Quantitative assessment of the p53-Mdm2 feedback loop using protein lysate microarrays. Cancer Res. 2007;67:6247-52 pubmed
|
Vairaktaris E, Kalokerinos G, Goutzanis L, Spyridonidou S, Vassiliou S, Derka S, et al. Diabetes alters expression of p53 and c-myc in different stages of oral oncogenesis. Anticancer Res. 2007;27:1465-73 pubmed
|
Clarke A, Jones N, Pryde F, Adachi Y, Sansom O. 53BP1 deficiency in intestinal enterocytes does not alter the immediate response to ionizing radiation, but leads to increased nuclear area consistent with polyploidy. Oncogene. 2007;26:6349-55 pubmed
|
Preyer M, Shu C, Wang J. Delayed activation of Bax by DNA damage in embryonic stem cells with knock-in mutations of the Abl nuclear localization signals. Cell Death Differ. 2007;14:1139-48 pubmed
|
Zhu Q, Wani G, Yao J, Patnaik S, Wang Q, El Mahdy M, et al. The ubiquitin-proteasome system regulates p53-mediated transcription at p21waf1 promoter. Oncogene. 2007;26:4199-208 pubmed
|
Bifsha P, Landry K, Ashmarina L, Durand S, Seyrantepe V, Trudel S, et al. Altered gene expression in cells from patients with lysosomal storage disorders suggests impairment of the ubiquitin pathway. Cell Death Differ. 2007;14:511-23 pubmed
|
Bertozzi C, Chang C, Jairaj S, Shan X, Huang J, Weber B, et al. Multiple initial culture conditions enhance the establishment of cell lines from primary ovarian cancer specimens. In Vitro Cell Dev Biol Anim. 2006;42:58-62 pubmed
|
Villar Suarez V, Colaco B, Calles Venal I, Bravo I, Fernandez Alvarez J, Fernandez Caso M, et al. Effects of extracellular matrix on the morphology and behaviour of rabbit auricular chondrocytes in culture. J Biomed Biotechnol. 2005;2005:364-73 pubmed
|
Ehrlichova M, Koc M, Truksa J, Naldová Z, Vaclavikova R, Kovárr J. Cell death induced by taxanes in breast cancer cells: cytochrome C is released in resistant but not in sensitive cells. Anticancer Res. 2005;25:4215-24 pubmed
|
Laud P, Multani A, Bailey S, Wu L, Ma J, Kingsley C, et al. Elevated telomere-telomere recombination in WRN-deficient, telomere dysfunctional cells promotes escape from senescence and engagement of the ALT pathway. Genes Dev. 2005;19:2560-70 pubmed
|
Meniel V, Hay T, Douglas Jones A, Sansom O, Clarke A. Mutations in Apc and p53 synergize to promote mammary neoplasia. Cancer Res. 2005;65:410-6 pubmed
|
Gruber A, Schmidt P, Url A. Immunohistochemical studies concerning the neuronal cell cycle of the cat using PCNA, Ki-67 and p53 markers. J Vet Med A Physiol Pathol Clin Med. 2004;51:416-9 pubmed
|
Rosas Acosta G, Russell W, Deyrieux A, Russell D, Wilson V. A universal strategy for proteomic studies of SUMO and other ubiquitin-like modifiers. Mol Cell Proteomics. 2005;4:56-72 pubmed
|
Mathur S, Kaur P, Sharma M, Katyal A, Singh B, Tiwari M, et al. The treatment of skin carcinoma, induced by UV B radiation, using 1-oxo-5beta, 6beta-epoxy-witha-2-enolide, isolated from the roots of Withania somnifera, in a rat model. Phytomedicine. 2004;11:452-60 pubmed
|
Hoogervorst E, Van Oostrom C, Beems R, van Benthem J, Gielis S, Vermeulen J, et al. p53 heterozygosity results in an increased 2-acetylaminofluorene-induced urinary bladder but not liver tumor response in DNA repair-deficient Xpa mice. Cancer Res. 2004;64:5118-26 pubmed
|
Poulin D, Kung A, DeCaprio J. p53 targets simian virus 40 large T antigen for acetylation by CBP. J Virol. 2004;78:8245-53 pubmed
|
Jayasurya R, Francis G, Kannan S, Lekshminarayanan K, Nalinakumari K, Abraham T, et al. p53, p16 and cyclin D1: molecular determinants of radiotherapy treatment response in oral carcinoma. Int J Cancer. 2004;109:710-6 pubmed
|
Ali S, Kasper J, Arai T, DeCaprio J. Cul7/p185/p193 binding to simian virus 40 large T antigen has a role in cellular transformation. J Virol. 2004;78:2749-57 pubmed
|
Facchetti M, Uberti D, Memo M, Missale C. Nerve growth factor restores p53 function in pituitary tumor cell lines via trkA-mediated activation of phosphatidylinositol 3-kinase. Mol Endocrinol. 2004;18:162-72 pubmed
|
Schwartz J, Muscat J, Baker V, Larios E, Stephenson G, Guo W, et al. Oral cytology assessment by flow cytometry of DNA adducts, aneuploidy, proliferation and apoptosis shows differences between smokers and non-smokers. Oral Oncol. 2003;39:842-54 pubmed
|
Masuda N, Kato H, Nakajima T, Sano T, Kashiwabara K, Oyama T, et al. Synergistic decline in expressions of p73 and p21 with invasion in esophageal cancers. Cancer Sci. 2003;94:612-7 pubmed
|
Gingras B, Rodier G, Giasson E, Coulombe P, Chassagne C, Meloche S. Expression of angiotensin type II receptor downregulates Cdk4 synthesis and inhibits cell-cycle progression. Oncogene. 2003;22:2633-42 pubmed
|
Oh S, Yun K, Nan J, Sohn D, Lee B. Changes in expression and immunolocalization of protein associated with toxic bile salts-induced apoptosis in rat hepatocytes. Arch Toxicol. 2003;77:110-5 pubmed
|
Smith K, Rhee J, Cleary M. Transformation of bone marrow B-cell progenitors by E2a-Hlf requires coexpression of Bcl-2. Mol Cell Biol. 2002;22:7678-87 pubmed
|
Uberti D, Carsana T, Bernardi E, Rodella L, Grigolato P, Lanni C, et al. Selective impairment of p53-mediated cell death in fibroblasts from sporadic Alzheimer's disease patients. J Cell Sci. 2002;115:3131-8 pubmed
|
Gajra A, Tatum A, Newman N, Gamble G, Lichtenstein S, Rooney M, et al. The predictive value of neuroendocrine markers and p53 for response to chemotherapy and survival in patients with advanced non-small cell lung cancer. Lung Cancer. 2002;36:159-65 pubmed
|
Calabrò V, Mansueto G, Parisi T, Vivo M, Calogero R, La Mantia G. The human MDM2 oncoprotein increases the transcriptional activity and the protein level of the p53 homolog p63. J Biol Chem. 2002;277:2674-81 pubmed
|
Graziano S, Tatum A, Herndon J, Box J, Memoli V, Green M, et al. Use of neuroendocrine markers, p53, and HER2 to predict response to chemotherapy in patients with stage III non-small cell lung cancer: a Cancer and Leukemia Group B study. Lung Cancer. 2001;33:115-23 pubmed
|
产品信息
产品类型 :
抗体
产品名称 :
p53单克隆抗体(多克隆抗体240)
目录# :
MA5-15244
规格 :
500微升
价格 :
美国447.00
克隆性 :
单克隆
纯度 :
蛋白质G
宿主 :
小鼠
反应物种 :
人类, 小鼠, 猕猴
应用 :
ChIP assay: 1-3 µg x 10^6 cells, Flow Cytometry: Assay-dependent, Immunocytochemistry: 2 µg/mL, Immunohistochemistry (Paraffin): 2-4 µg/mL, Immunoprecipitation: 2 µg/mL, Western Blot: 1-2 µg/mL
物种 :
人类, 小鼠, 猕猴
克隆 :
多克隆抗体240
抗体亚型 :
IgG1
储存 :
4° C
描述 :
The tumor suppressor protein, p53, is a sequence specific transcription factor that is activated by cellular stress. p53 mediates cell cycle arrest or apoptosis in response to DNA damage or starvation for pyrimidine nucleotides. p53 is up-regulated in response to stress signals and stimulated to activate transcription of specific genes, resulting in expression of p21waf1 and other proteins involved in G1 or G2/M arrest. The structure of p53 comprises an N-terminal transactivation domain, a central DNA-binding domain, an oligomerisation domain, and a C-terminal regulatory domain. There are various phosphorylation sites on p53, of which the phosphorylation at Ser15 is important for p53 activation and stabilization. p53 has been characterized to play a role in blocking the proliferative action of damaged cells and act as an anticancer agent. Phosphorylation of Ser392 in p53 has been shown to associate with the formation of human tumors. In addition, p53 has also been linked to the effects of aging and oxidative stress and an increase in p53 has been linked to deficits in LTP (Long Term Potentiation) in learning and memory. p53 is found in very low levels in normal cells, however, in a variety of transformed cell lines, it is expressed in high amounts, and believed to contribute to transformation and malignancy. Mutants of p53 that frequently occur in a number of different human cancers fail to bind the consensus DNA binding site, and cause the loss of tumor suppressor activity. Alterations of the TP53 gene occur not only as somatic mutations in human malignancies, but also as germline mutations in some cancer-prone families such as Li-Fraumeni syndrome.
免疫原 :
Murine p53 protein corresponding to aa14-289
格式 :
液体
应用w/稀释 :
ChIP assay: 1-3 µg x 10^6 cells, Flow Cytometry: Assay-dependent, Immunocytochemistry: 2 µg/mL, Immunohistochemistry (Paraffin): 2-4 µg/mL, Immunoprecipitation: 2 µg/mL, Western Blot: 1-2 µg/mL
别名 :
Antigen NY-CO-13; bbl; BCC7; bfy; bhy; cellular tumor antigen p53; Cys 51 Stop; EGK_08142; FLJ92943; HGNC11998; I79_002739; LFS1; Li-Fraumeni syndrome; mutant p53; mutant tumor protein 53; OTTMUSP00000006194; p44; p53; p53 cellular tumor antigen; p53 protein; p53 tumor suppressor; p53 tumor suppressor phosphoprotein; phosphoprotein p53; Tp53; tp53.L; transformation related protein 53; transformation-related protein 53; Trp248; Trp53; tumor protein 53; tumor protein p53; tumor protein p53 (Li-Fraumeni syndrome); tumor protein p53 L homeolog; tumor suppressor p53; tumor suppressor p53 phosphoprotein; tumor suppressor protein p53; tumor supressor p53; Tumour Protein p53; XELAEV_180196761mg; Xp53; Xrel3
更多信息或购买 :
公司信息
赛默飞世尔